-
Iranian satire 'Head to Head' draws a veil over the men
-
Colombians in Santa Marta stay inside after violence wracks the city
-
Archaeological 'breakthrough' could confirm origins of Paris
-
Iran airlines cancel flights as US sanctions hit
-
Morocco elects new parliament with lowest turnout in nearly two decades
-
Meta launches camera-free AI glasses amid privacy pushback
-
North Korean IT contractor found remote work in New Zealand: agency
-
Australian PM says OpenAI hacked government health website
-
Anthropic touts AI-led biology discovery
-
Xi arrives in US to personal Trump welcome
-
Giants QB Dart to have season-ending surgery
-
Morocco elects new parliament amid social frustration, youth discontent
-
Venezuelan shot by ICE needs urgent surgery, mother tells AFP
-
Scheffler and Burns to face Im and Lee in Presidents Cup opener
-
Giants QB Dart to have season-ending surgery: reports
-
Crushing wins for Lyon and Barca in women's Champions League
-
Judge urged to lift Trump's White House ban on media outlets
-
Rio breaks record for rainiest September amid powerful El Nino
-
Stocks fall on soaring bond yields, higher oil prices
-
At UN, tech chiefs urge caution in AI development
-
US judge weighing Trump's White House ban on media outlets
-
Russian strikes kill seven in Ukraine, Zelensky vows winter campaign
-
At UN, OpenAI's Altman calls 'for extreme care' in AI
-
Venezuelan shot by ICE needs urgent medical care, mother tells AFP
-
Hamilton gives thumbs up to Gulf GPs despite Iran conflict
-
Zelensky says Putin using fighters from 47 countries in Ukraine war
-
Leclerc admits going 'too far' in Hamilton shunt in Italy
-
Klopp calls on Germany to 'rise above ourselves' as new era begins
-
Row engulfs Dolly Parton's estate as manager accuses nephew of making threats
-
Russian strikes kill seven in Ukraine as Russia vows no 'pause' to war
-
Mandela Digital Extends Early Access Programme to 11 February 2027 Following Strong Response
-
ArcPoint Expands Globally with Institutional Intelligence Platform for Modern Investors
-
US seeks 11th Presidents Cup win in a row over global foes
-
Ronaldo focussing on 'present' ahead of Wales test
-
McDonald's to boost franchisees as inflation weighs on consumers
-
Outgoing UN chief makes final climate push at New York summit
-
Trump invites Putin to G20 summit in Miami
-
Grief and pain flow at hearing for Canadian suicide poison vendor
-
Archaelogical 'breakthrough' could confirm origins of Paris
-
Ireland boss Hallgrimsson says timing of Israel remarks 'not clever'
-
ILO financial crisis takes centre stage in leadership race
-
Weinstein resentenced to 15 years in prison for 2006 sex assault
-
Stocks dip, oil soars despite Trump hailing "productive" Iran talks
-
Fendi brings disco bling, Italian style, to Milan Fashion Week
-
China's Xi to get rare airport welcome from Trump
-
French court confirms rape trial for PSG and Morocco star Hakimi
-
Turkey reassures investors over investment fund crisis
-
President tells Trump that Iran will never 'bend at the knee'
-
Saka says England still have 'scar' from World Cup semi-final loss
-
أليكس بودي والبروفيسور الدكتور شتيفان هاوبت يتفقان على التعاون من أجل مجموعة فنية أسطورية في رومانيا
NEW REPORT: How High Prescription Drug Prices Shape the Lives of Hispanic and Latino Families
WASHINGTON, D.C. / ACCESS Newswire / September 2, 2026 / Hispanic and Latino patients are delaying treatment, rationing medication, taking on debt, and traveling abroad to purchase prescription drugs because they cannot afford the high prices charged in the United States, according to a new report released today by Patients For Affordable Drugs, We Are Más, and Brown University's Information Futures Lab.
The Price Patients Pay: How Unaffordable Prescription Drugs Shape the Health, Finances, and Daily Lives of Hispanic and Latino Communitiesoffers a look beyond national statistics and examines the experiences of patients navigating the U.S. prescription drug affordability crisis. The report offers actionable recommendations for policymakers, healthcare providers, advocacy organizations, philanthropists, and community leaders to improve prescription drug affordability, hold those in power accountable, and help ensure patients can access the medications they need.

Read the full report in English here, and in Spanish here
"Prescription drug prices are high because the system in the U.S. allows drug companies to charge prices that are at least four times higher than what patients in other countries pay," said Merith Basey, CEO of Patients For Affordable Drugs. "Those prices adversely affect Hispanic and Latino communities at a higher rate, yet their experiences are too often absent from the conversations about the solutions. This report helps ensure their voices are included in the fight to make prescription drugs more affordable."
"Many of the people we spoke with know firsthand that the same medicines can be far more affordable in other countries. That perspective makes it very clear that these prices are not inevitable," said Evelyn Pèrez-Verdïa, CEO of the bilingual social impact agency, We Are Más. "Families are drawing on relatives, community networks, and connections across borders to get the medicines they need. But those networks should be a source of strength, not a substitute for an affordable healthcare system."
"A health system that can identify and procure the medicine that could keep someone well-or alive-and then make that medicine financially unreachable is failing at its most basic job," said Stefanie Friedhoff, Professor of the Practice and director of the Information Futures Lab at Brown University School of Public Health. "In a country with the resources of the United States, that is not only a health care problem; it is a public health failure. Too often the consequences are blamed on patients rather than the systems that produced them."
While polling shows that Hispanic and Latino communities are disproportionately burdened by high prescription drug prices, this report goes beyond the data to document the lived experiences of Hispanic, Latino, and Spanish-speaking adults in South Florida. Through five weeks of interviews, weekly questionnaires, and community discussions-most conducted in Spanish-it captures the difficult decisions families make when medicines become unaffordable, the emotional toll of those choices, and the strategies patients use to stay healthy.
While every participant's story was unique, several clear themes emerged throughout the project.
Patients are forced to choose between medicine and basic necessities. Participants regularly described deciding between filling prescriptions, buying groceries, paying rent, or covering utility bills, often at the expense of their health and financial stability.
"Just imagine not having the medication you need to survive...the sheer anguish of knowing that the medication exists, yet being unable to go get it, is horrible."
The consequences extend far beyond financial hardship. High prescription drug prices contributed to chronic stress, anxiety, social isolation, strained family relationships, and fear about losing access to lifesaving medications.
Patients view unaffordable prescription drugs as the result of systemic failures, not personal choices.
"Everyone here in the U.S. should have access to affordable medication - after all, I see that in other countries, many people enjoy that benefit."
Patients developed risky strategies to access lifesaving drugs. Participants reported rationing medications, delaying treatment, purchasing prescriptions abroad, relying on credit cards, searching extensively for lower-cost options, and turning to family and community networks when the healthcare system failed them.
Community networks are critical - but lasting solutions require systemic reform. While support from trusted healthcare providers, family members, and community organizations helped participants navigate the system, they consistently emphasized that lasting relief will require systemic reform.
"It often feels like the system makes it harder on purpose so patients end up paying full price"
Within the report, readers will also find additional patient stories, in-depth analysis of the project's key themes, and recommendations informed directly by participants' experiences.
Read the full report in English here, and in Spanish here.
###
Patients For Affordable Drugs is the only national patient advocacy organization focused exclusively on policies that lower prescription drug prices. We empower and mobilize patients by amplifying their experiences with high drug prices to hold those in power accountable and fight to shape and achieve system-changing policies that make prescription drugs affordable for all people in the United States. P4AD does not accept funding from organizations that profit from the development or distribution of drugs. To learn more, visit: PatientsForAffordableDrugs.org
We Are Más is a South Florida-based social impact organization specializing in culturally competent, hyperlocal engagement with diaspora groups in Hispanic, English- and Spanish-speaking communities. Working with a variety of purpose-driven organizations across the public, private, and third sectors, We Are Más combines listening and an active local presence with research and strategic communications to support partners in connecting deeply with communities in diverse places such as South Florida, Texas, and other Hispanic communities across the U.S.
Brown University's Information Futures Lab is a new type of university hub. Interdisciplinary researchers work alongside organizations, journalists, civic society leaders, and other sources of trusted information to respond to the information crisis as a civic and public health threat. Recognizing information as a social determinant of health, we create an evidence base and work with our partners to improve information ecosystems and strengthen the capacity of citizens to effectively access, create, and make sense of information that is crucial to their well-being. Learn more about the Information Futures Lab and its initiatives on our website.
CONTACT: Brennan Fiske [email protected]
SOURCE: Patients For Affordable Drugs
View the original press release on ACCESS Newswire
M.Fischer--AMWN